Skip to main content

Genomatica Nabs UCSD, Penn State Bioengineering Licenses

NEW YORK, April 26-Privately held systems biology company Genomatica said on Wednesday that it has licensed bioengineering technology from the University of California, San Diego and the Pennsylvania State University.

 

These licenses, said the company, give it an edge in constraints-based modeling of metabolic and other regulatory processes.

 

Through the licenses, Genomatica gets access to the work of UCSD bioengineer Bernhard Paisson, and the regulatory network research of Penn State's Costas Maranas.

 

"These technologies will enable the integrated modeling of metabolism and regulation, positioning the company as a leader in the emerging field of in silico biology," said VP Christophe Schilling in a statement.

 

Constraints-based modeling, in Genomatica's work, seeks to integrate gene, protein, metabolite and phenotype information to create models of cellular activity.

 

Genomatica is based in San Diego, Calif.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.